Research Solutions (RSSS) 10-Q 16 Nov 15 2016 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Sep. 30, 2015	Nov. 06, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	1,386,301
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RSSS
Entity Common Stock, Shares Outstanding		18,392,277

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Current assets:
Cash and cash equivalents	$ 1,465,026	$ 1,354,158
Accounts receivable, net of allowance of $56,835 and $69,731, respectively	4,964,622	4,889,937
Prepaid expenses and other current assets	52,383	70,195
Prepaid royalties	518,626	372,581
Total current assets	7,000,657	6,686,871
Other assets:
Property and equipment, net of accumulated depreciation of $599,633 and $585,410, respectively	68,100	83,238
Deposits and other assets	9,376	9,471
Total assets	7,078,133	6,779,580
Current liabilities:
Accounts payable and accrued expenses	5,855,783	5,611,453
Deferred revenue	164,666	75,311
Total current liabilities	6,020,449	5,686,764
Stockholders’ equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 18,392,277 and 18,242,125 shares issued and outstanding, respectively	18,392	18,242
Additional paid-in capital	16,330,193	16,188,358
Accumulated deficit	(15,263,257)	(15,084,437)
Accumulated other comprehensive loss	(27,644)	(29,347)
Total stockholders’ equity	1,057,684	1,092,816
Total liabilities and stockholders’ equity	$ 7,078,133	$ 6,779,580

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets [Parenthetical] - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Allowance for Doubtful Accounts Receivable, Current	$ 56,835	$ 69,731
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 599,633	$ 585,410
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	18,392,277	18,242,125
Common Stock, Value, Outstanding	$ 18,392,277	$ 18,242,125

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 8,027,101	$ 7,553,396
Cost of revenue	6,472,754	6,053,591
Gross profit	1,554,347	1,499,805
Operating expenses:
Selling, general and administrative	1,704,961	1,426,315
Depreciation and amortization	14,738	72,088
Total operating expenses	1,719,699	1,498,403
Income (loss) from operations	(165,352)	1,402
Other income (expenses):
Interest expense	(4,993)	(3,198)
Other income (expense)	2,769	298
Total other expenses	(2,224)	(2,900)
Loss from continuing operations before provision for income taxes	(167,576)	(1,498)
Provision for income taxes	(11,244)	(5,438)
Loss from continuing operations	(178,820)	(6,936)
Discontinued operations:
Loss from discontinued operations	0	(395,344)
Gain from deconsolidation of former French subsidiary	0	1,548,295
Income from discontinued operations	0	1,152,951
Net income (loss)	(178,820)	1,146,015
Other comprehensive income (loss):
Foreign currency translation	1,703	(4,356)
Comprehensive income (loss)	$ (177,117)	$ 1,141,659
Basic income (loss) per common share:
Loss per share from continuing operations	$ (0.01)	$ 0
Income per share from discontinued operations	0	0.07
Net income (loss) per share	$ (0.01)	$ 0.07
Basic weighted average common shares outstanding	17,564,070	17,406,012
Diluted income (loss) per common share:
Loss per share from continuing operations	$ (0.01)	$ 0
Income per share from discontinued operations	0	0.07
Net income (loss) per share	$ (0.01)	$ 0.07
Diluted weighted average common shares outstanding	17,564,070	17,407,428

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Stockholders' Equity - 3 months ended Sep. 30, 2015 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]
Balance at Jun. 30, 2015	$ 1,092,816	$ 18,242	$ 16,188,358	$ (15,084,437)	$ (29,347)
Balance (in shares) at Jun. 30, 2015		18,242,125
Fair value of vested stock options	(56,574)	$ 0	56,574	0	0
Fair value of vested restricted common stock	87,167	$ 152	87,015	0	0
Fair value of vested restricted common stock (in shares)		152,000
Common stock repurchase and retirement	(1,756)	$ (2)	(1,754)	0	0
Common stock repurchase and retirement (in shares)		(1,848)
Net loss for the period	(178,820)	$ 0	0	(178,820)	0
Foreign currency translation	1,703	0	0	0	1,703
Balance at Sep. 30, 2015	$ 1,057,684	$ 18,392	$ 16,330,193	$ (15,263,257)	$ (27,644)
Balance (in shares) at Sep. 30, 2015		18,392,277

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flow from operating activities:
Net income (loss)	$ (178,820)	$ 1,146,015
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities of continuing operations:
Loss from discontinued operations	0	395,344
Gain from deconsolidation of former French subsidiary	0	(1,548,295)
Depreciation and amortization	14,738	72,088
Fair value of vested stock options	56,574	61,348
Fair value of vested restricted common stock	87,167	46,371
Changes in operating assets and liabilities:
Accounts receivable	(74,685)	(178,781)
Prepaid expenses and other current assets	17,812	15,288
Prepaid royalties	(146,045)	(46,845)
Deposits and other assets	95	52
Accounts payable and accrued expenses	244,330	(237,298)
Deferred revenue	89,355	0
Other liability	0	187,907
Net cash provided by (used in) operating activities from continuing operations	110,521	(86,806)
Net cash used in operating activities of discontinued operations	0	(34,503)
Net cash provided by (used in) operating activities	110,521	(121,309)
Cash flow from investing activities:
Purchase of property and equipment	0	(9,731)
Purchase of intangible assets	0	(8,490)
Net cash used in investing activities from continuing operations	0	(18,221)
Cash flow from financing activities:
Advance under line of credit	500,000	500,000
Payment under line of credit	(500,000)	(500,000)
Common stock repurchase and retirement	(1,756)	0
Net cash used in financing activities from continuing operations	(1,756)	0
Net cash used in financing activities of discontinued operations	0	(67,515)
Net cash used in financing activities	(1,756)	(67,515)
Effect of exchange rate changes	2,103	(142,207)
Net increase (decrease) in cash and cash equivalents	110,868	(349,252)
Cash and cash equivalents, beginning of period	1,354,158	1,884,667
Cash and cash equivalents, end of period	1,465,026	1,535,415
Supplemental disclosures of cash flow information:
Cash paid for income taxes	11,244	5,438
Cash paid for interest	$ 4,993	$ 3,198

Organization, Nature of Busines

Organization, Nature of Business and Basis of Presentation	3 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Nature of Business and Basis of Presentation	Note 1. Organization, Nature of Business and Basis of Presentation Organization Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006. On March 4, 2013, we consummated a merger with DYSC Subsidiary Corporation, our wholly-owned subsidiary, pursuant to which we, in connection with such merger, amended our Articles of Incorporation to change our name to Research Solutions, Inc. (formerly Derycz Scientific, Inc.). Research Solutions, Inc. is a publicly traded holding company with two wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation (“Reprints Desk”) and Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico (“Reprints Desk Latin America”). On August 18, 2014, the Board of Directors of the Company authorized the immediate disposal of the Company’s former subsidiary Techniques Appliquées aux Arts Graphiques, S.p.A. (“TAAG”), an entity organized under the laws of France, at a reasonable price in relation to its current fair value, and in the event such sale was not consummated by September 10, 2014, that management proceed with an insolvency filing by TAAG under French law. On September 15, 2014, the French Tribunal de Commerce appointed an Administrator for TAAG following a declaration of insolvency by our legal representative, and on October 6, 2014 TAAG entered into a judicial liquidation procedure. As a result, effective September 15, 2014, the Company relinquished control of TAAG to the Tribunal and TAAG ceased to be our subsidiary and was deconsolidated from our financial statements. The Company derecognized the assets, liabilities and other comprehensive income of TAAG with a resulting non-cash gain on deconsolidation of $ 1,548,295 Nature of Business We provide on-demand access to scientific, technical, and medical (“STM”) information for life science companies, academic institutions, and other research-intensive organizations. We provide two types of services to our customers: Article Galaxy, and Reprints and ePrints. Article Galaxy Article Galaxy, our cloud-based software-as-a-service (“SaaS”) solution, provides our customers with a single source to the universe of published STM content that includes over seventy million existing STM articles and over one million newly published STM articles each year. Article Galaxy allows customers to find and download in digital format STM articles that are critical to their research. In addition, Article Galaxy facilitates customers’ compliance with applicable copyright laws. Researchers and regulatory personnel in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. They place orders with us for the articles they need and we source and electronically deliver the requested content to them generally in under an hour. This service is known in the industry as single article delivery or document delivery. We also obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. We have arrangements with numerous content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Even though single article delivery services are charged on a transactional basis, customer order volume tends to be consistent from month to month in part due to consistent orders of larger customers that require the implementation of our services into their work flow, subject to fluctuations due to the addition or loss of customers. We deliver the aforementioned services through our Article Galaxy journal article platform (“Article Galaxy”), which consists of proprietary software and Internet-based interfaces that allow customers to initiate orders, manage transactions, obtain reporting, automate authentication, improve seamless connectivity to corporate intranets, and enhance the information resources they already own, or have access to via subscriptions or internal libraries, as well as organize workgroups to collaborate around scientific information. As a cloud-based SaaS solution, Article Galaxy is deployed as a single system across our entire customer base. Customers access Article Galaxy securely through online web interfaces and via web service APIs, which enable customers to leverage Article Galaxy features and functionality from within proprietary and other 3rd party software systems. Article Galaxy can also be configured to satisfy a customer’s individual preferences in areas such as user experience, business processes, and spend management. As a SaaS solution, Article Galaxy benefits from efficiencies in scalability, stability and development costs, resulting in significant advantages versus multiple instance or installed desktop software alternatives. We leverage these technical efficiencies to fuel rapid innovation and competitive advantage. Reprints and ePrints Marketing departments in life science and other research-intensive organizations generally require large quantities of printed copies of published STM journal articles called “Reprints” that are distributed to physicians and at conferences. We obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. Electronic copies, called “ePrints”, are also used for distribution through the Internet and other electronic mechanisms. We have developed proprietary ePrint software that increases the efficiency of our customers’ content purchases by transitioning from paper Reprints to electronic ePrints, and by improving compliance with applicable copyright laws and promotional regulations within the life science industry. Reprints and ePrints are charged on a transactional basis and order volume typically fluctuates from month to month based on customer marketing budgets and the existence of STM journal articles that fit customer requirements. Principles of Consolidation The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2015 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2015 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions. Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 94,937 112,880 The following table summarizes revenue concentrations: Three Months Ended September 30, 2015 2014 Customer A 11 % 11 % As of September 30, June 30, 2015 2015 Customer A * 13 % Three Months Ended September 30, 2015 2014 Vendor A 17 % 14 % Vendor B * 13 % * Less than 10% The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two types of services to our customers: Article Galaxy, and Reprints and ePrints. Article Galaxy We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Reprints and ePrints We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (FASB) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates. The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the discontinued operations of our former French subsidiary are in Euros, and the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $ 1,317 10,847 Three Months Ended Year Ended September 30, June 30, 2015 2014 2015 2014 Period end Euro : US Dollar exchange rate 1.12 1.27 1.11 1.36 Average period Euro : US Dollar exchange rate 1.11 1.33 1.20 1.36 Period end Mexican Peso : US Dollar exchange rate 0.06 0.07 0.06 0.08 Average period Mexican Peso : US Dollar exchange rate 0.06 0.08 0.07 0.08 Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At September 30, 2015 potentially dilutive securities include options to acquire 2,508,503 305,000 1,948,351 904,998 Basic and diluted net loss per common share is the same for the three months ended September 30, 2015 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. For the three months ended September 30, 2014, the calculation of diluted earnings per share includes stock options and warrants, calculated under the treasury stock method. Three Months Ended September 30, 2015 2014 Numerator: Loss from continuing operations $ (178,820) $ (6,936) Income (loss) from discontinued operations - 1,152,951 Net income (loss) $ (178,820) $ 1,146,015 Denominator: Weighted average shares outstanding (basic) 17,564,070 17,406,012 Effect of dilutive unvested restricted common stock - - Effect of dilutive stock options and warrants - 1,416 Weighted average shares outstanding (diluted) 17,564,070 17,407,428 Income (loss) per share from continuing operations: Basic $ (0.01) $ - Diluted $ (0.01) $ - Income (loss) per share from discontinued operations: Basic $ - $ 0.07 Diluted $ - $ 0.07 Net income (loss) per share: Basic $ (0.01) $ 0.07 Diluted $ (0.01) $ 0.07 In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718) Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line of Credit

Line of Credit	3 Months Ended
	Sep. 30, 2015
Line of Credit Facility [Abstract]
Line of Credit	Note 3. Line of Credit The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $ 4,000,000 80 October 31, 2017 Financial covenants include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $600,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2015, plus 50% of the dollar value of equity issuances after October 1, 2015 and the principal amount of subordinated debt. 2.25 800,000 the prime rate plus 5.25% 5.75 There were no outstanding borrowings under the line as of September 30, 2015 and June 30, 2015, respectively. As of September 30, 2015 and June 30, 2015, approximately $ 1,600,000 2,182,000

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 4. Stockholders’ Equity Stock Options In December 2007, we established the 2007 Equity Compensation Plan (the “Plan”). The Plan was approved by our board of directors and stockholders. The purpose of the Plan is to grant stock and options to purchase our common stock to our employees, directors and key consultants. On November 21, 2014, the maximum number of shares of common stock that may be issued pursuant to awards granted under the Plan (including issuance of restricted common stock) increased from 3,000,000 5,000,000 1,314,842 The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period. All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at June 30, 2015 2,466,836 $ 1.22 2,256,254 $ 1.21 210,582 $ 1.29 Granted 41,667 0.86 31,000 0.85 10,667 0.90 Options vesting - - 53,588 1.24 (53,588) 1.24 Exercised - - - - - - Forfeited/Cancelled - - - - - - Outstanding at September 30, 2015 2,508,503 $ 1.22 2,340,842 $ 1.21 167,661 $ 1.28 The weighted average remaining contractual life of all options outstanding as of September 30, 2015 was 6.32 6.62 20,531 13,456 56,574 129,972 Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.65 6,150 9.11 - 0.77 59,500 8.89 33,542 0.80 16,000 9.90 16,000 0.90 25,667 9.85 15,000 1.00 370,890 3.42 347,000 1.02 287,000 4.83 287,000 1.05 158,445 9.65 150,000 1.07 53,898 7.05 53,898 1.10 330,000 9.76 330,000 1.15 278,000 7.36 267,333 1.20 31,414 8.64 15,707 1.25 32,000 7.38 29,333 1.30 263,000 6.43 263,000 1.50 380,000 2.31 380,000 1.75 1,067 8.33 534 1.80 190,050 7.98 131,665 1.85 24,000 7.64 20,000 1.97 1,422 8.15 830 Total 2,508,503 2,340,842 Warrants Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2015 305,000 $ 1.26 Granted - - Exercised - - Expired - - Outstanding, September 30, 2015 305,000 $ 1.26 Exercisable, June 30, 2015 305,000 $ 1.26 Exercisable, September 30, 2015 305,000 $ 1.26 There was no intrinsic value for all warrants outstanding as of September 30, 2015, based on the fair value of the Company’s common stock on September 30, 2015. Remaining Warrant Warrants Contractual Warrants Exercise Price Outstanding Life (in years) Exercisable $ 1.19 150,000 6.23 150,000 1.25 150,000 5.10 150,000 3.50 2,500 0.75 2,500 4.00 2,500 0.75 2,500 Total 305,000 305,000 Restricted Common Stock Prior to July 1, 2015, the Company issued 889,321 971,897 405,504 During the three months ended September 30, 2015, the Company issued an additional 152,000 136,800 0.90 The total fair value of restricted common stock vested during the three months ended September 30, 2015 was $ 87,167 616,026 Weighted Average Number of Grant Date Shares Fair Value Non-vested, June 30, 2015 736,746 0.96 Granted 152,000 0.90 Vested (129,539) 0.92 Forfeited - - Non-vested, September 30, 2015 759,207 $ 0.95 Common Stock Repurchase and Retirement On November 7, 2014 the Company’s Board of Directors authorized the repurchase of up to $ 250,000 1,848 1,756 53,300 0.93 49,482 200,518 Shares repurchased are retired and deducted from common stock for par value and from additional paid in capital for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares. Purchases may be made from time to time in open market or privately negotiated transactions as determined by the Company’s management. The actual timing, number and value of shares repurchased will be determined by the Company’s management at its discretion, and will depend on management's evaluation of market conditions and other factors. The Company has no obligation to repurchase any shares under this authorization, and the repurchase program may be suspended, discontinued or modified at any time, for any reason and without notice.

Income Taxes

Income Taxes	3 Months Ended
	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 5. Income Taxes For the three months ended September 30, 2015, the Company incurred a net loss of $178,820. For the three months ended September 30, 2014, net income was $1,146,015 and the Company did not record any provision for income taxes primarily because the gain from deconsolidation of our former French subsidiary (discussed further in note 6) was a non-taxable disposition of the Company’s interest in its former French subsidiary. In accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes, the Company evaluates its deferred tax assets to determine if a valuation allowance is required based on the consideration of all available evidence using a “more likely than not” standard, with significant weight being given to evidence that can be objectively verified. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability; the length of statutory carryover periods for operating losses and tax credit carryovers; and available tax planning alternatives. Our deferred tax assets are composed primarily of U.S. federal net operating loss carryforwards and temporary differences related to stock based compensation. Based on available objective evidence, management believes it is more likely than not that these deferred tax assets are not recognizable and will not be recognizable until its determined that we have sufficient taxable income. We may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. ASC 740 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods, and disclosures. As of September 30, 2015, the Company does not have any liabilities for unrecognized tax uncertainties.

Deconsolidation of Former Frenc

Deconsolidation of Former French Subsidiary (TAAG)	3 Months Ended
	Sep. 30, 2015
Discontinued Operations and Disposal Groups [Abstract]
Deconsolidation of Former French Subsidiary (TAAG)	Note 6. Deconsolidation of Former French Subsidiary (TAAG) On August 18, 2014 the Board of Directors of the Company authorized management to commit to a plan to sell TAAG. The Company concluded that TAAG’s printing operations in the major geographical area of France were not aligned with the Company’s long term strategy. Accordingly, the operations of TAAG were classified as discontinued operations and comparative information for prior periods has been restated to segregate the assets, liabilities, revenue, expenses, and cash flows related to TAAG as discontinued operations. Further, the Board of Directors of the Company authorized the disposal of TAAG at a reasonable price in relation to its current fair value, and in the event such sale was not consummated by September 10, 2014, that management proceed with an insolvency filing by TAAG under French law. On September 15, 2014, the French Tribunal de Commerce appointed an Administrator for TAAG following a declaration of insolvency by our legal representative, and on October 6, 2014 TAAG entered into a judicial liquidation procedure. As a result, effective September 15, 2014, the Company relinquished control of TAAG to the Tribunal and TAAG ceased to be our subsidiary and was deconsolidated from our financial statements. The Company deconsolidated the assets, liabilities and other comprehensive income of TAAG with a resulting non-cash gain on deconsolidation of $1,548,295 recorded on the consolidated statements of operations for the three months ended September 30, 2014. Description Amount Current assets $ (1,239,713) Property and equipment, net (359,677) Noncurrent assets (499,070) Current liabilities 3,442,857 Long term liabilities 95,051 Accumulated other comprehensive income 108,847 Total $ 1,548,295 In addition, comparative information for prior periods have been restated to segregate the assets, liabilities, revenue, expenses, and cash flows related to TAAG as discontinued operations. The Company has determined based on discussions with French counsel that it is remote that the Company will be liable for the unsatisfied liabilities of TAAG as a result of the insolvency process in France, and as a result, the Company has eliminated any respective liability as of June 30, 2015. Three Months Ended September 30, 2015 2014 Revenue $ - $ 1,164,314 Cost of revenue - 849,174 Gross profit - 315,140 Operating expenses: Selling, general and administrative - 660,500 Depreciation and amortization - 44,027 Total operating expenses - 704,527 Loss from discontinued operations before other income (expenses) - (389,387) Other income (expenses): Interest expense - (5,957) Loss from discontinued operations $ - $ (395,344) Basic loss per common share: Loss per share from discontinued operations $ - $ (0.02) Basic weighted average common shares outstanding - 17,406,012 Diluted loss per common share: Loss per share from discontinued operations $ - $ (0.02) Diluted weighted average common shares outstanding - 17,407,428

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 7. Subsequent Events On October 31, 2015 the Company amended the Loan and Security Agreement with SVB to extend the maturity date of the line of credit to October 31, 2017. The financial and performance covenants of the line of credit have been updated, while the remaining material terms remain mostly unchanged.

Summary of Significant Accoun14

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 94,937 112,880 The following table summarizes revenue concentrations: Three Months Ended September 30, 2015 2014 Customer A 11 % 11 % As of September 30, June 30, 2015 2015 Customer A * 13 % Three Months Ended September 30, 2015 2014 Vendor A 17 % 14 % Vendor B * 13 % * Less than 10%
Revenue Recognition	Revenue Recognition The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two types of services to our customers: Article Galaxy, and Reprints and ePrints. Article Galaxy We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Reprints and ePrints We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (FASB) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency Transactions	Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the discontinued operations of our former French subsidiary are in Euros, and the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $ 1,317 10,847 Three Months Ended Year Ended September 30, June 30, 2015 2014 2015 2014 Period end Euro : US Dollar exchange rate 1.12 1.27 1.11 1.36 Average period Euro : US Dollar exchange rate 1.11 1.33 1.20 1.36 Period end Mexican Peso : US Dollar exchange rate 0.06 0.07 0.06 0.08 Average period Mexican Peso : US Dollar exchange rate 0.06 0.08 0.07 0.08
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At September 30, 2015 potentially dilutive securities include options to acquire 2,508,503 305,000 1,948,351 904,998 Basic and diluted net loss per common share is the same for the three months ended September 30, 2015 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. For the three months ended September 30, 2014, the calculation of diluted earnings per share includes stock options and warrants, calculated under the treasury stock method. Three Months Ended September 30, 2015 2014 Numerator: Loss from continuing operations $ (178,820) $ (6,936) Income (loss) from discontinued operations - 1,152,951 Net income (loss) $ (178,820) $ 1,146,015 Denominator: Weighted average shares outstanding (basic) 17,564,070 17,406,012 Effect of dilutive unvested restricted common stock - - Effect of dilutive stock options and warrants - 1,416 Weighted average shares outstanding (diluted) 17,564,070 17,407,428 Income (loss) per share from continuing operations: Basic $ (0.01) $ - Diluted $ (0.01) $ - Income (loss) per share from discontinued operations: Basic $ - $ 0.07 Diluted $ - $ 0.07 Net income (loss) per share: Basic $ (0.01) $ 0.07 Diluted $ (0.01) $ 0.07
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718) Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary of Significant Accoun15

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Schedule of Revenue by Major Customers	Three Months Ended September 30, 2015 2014 Customer A 11 % 11 %
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	The following table summarizes accounts receivable concentrations: As of September 30, June 30, 2015 2015 Customer A * 13 %
Schedule of Concentration of Risk	Three Months Ended September 30, 2015 2014 Vendor A 17 % 14 % Vendor B * 13 % * Less than 10%
Schedule Of Foreign Currency Exchange Rate	The following table summarizes the exchange rates used: Three Months Ended Year Ended September 30, June 30, 2015 2014 2015 2014 Period end Euro : US Dollar exchange rate 1.12 1.27 1.11 1.36 Average period Euro : US Dollar exchange rate 1.11 1.33 1.20 1.36 Period end Mexican Peso : US Dollar exchange rate 0.06 0.07 0.06 0.08 Average period Mexican Peso : US Dollar exchange rate 0.06 0.08 0.07 0.08
Schedule of Earnings Per Share, Basic and Diluted	The calculation of basic and diluted net income (loss) per share is presented below: Three Months Ended September 30, 2015 2014 Numerator: Loss from continuing operations $ (178,820) $ (6,936) Income (loss) from discontinued operations - 1,152,951 Net income (loss) $ (178,820) $ 1,146,015 Denominator: Weighted average shares outstanding (basic) 17,564,070 17,406,012 Effect of dilutive unvested restricted common stock - - Effect of dilutive stock options and warrants - 1,416 Weighted average shares outstanding (diluted) 17,564,070 17,407,428 Income (loss) per share from continuing operations: Basic $ (0.01) $ - Diluted $ (0.01) $ - Income (loss) per share from discontinued operations: Basic $ - $ 0.07 Diluted $ - $ 0.07 Net income (loss) per share: Basic $ (0.01) $ 0.07 Diluted $ (0.01) $ 0.07

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Weighted Weighted Weighted Average Average Average Exercise Exercise Exercise Shares Price Shares Price Shares Price Outstanding at June 30, 2015 2,466,836 $ 1.22 2,256,254 $ 1.21 210,582 $ 1.29 Granted 41,667 0.86 31,000 0.85 10,667 0.90 Options vesting - - 53,588 1.24 (53,588) 1.24 Exercised - - - - - - Forfeited/Cancelled - - - - - - Outstanding at September 30, 2015 2,508,503 $ 1.22 2,340,842 $ 1.21 167,661 $ 1.28
Schedule of Share-based Compensation, by Exercise Price Range	Additional information regarding stock options outstanding and exercisable as of September 30, 2015 is as follows: Option Remaining Exercise Options Contractual Options Price Outstanding Life (in years) Exercisable $ 0.65 6,150 9.11 - 0.77 59,500 8.89 33,542 0.80 16,000 9.90 16,000 0.90 25,667 9.85 15,000 1.00 370,890 3.42 347,000 1.02 287,000 4.83 287,000 1.05 158,445 9.65 150,000 1.07 53,898 7.05 53,898 1.10 330,000 9.76 330,000 1.15 278,000 7.36 267,333 1.20 31,414 8.64 15,707 1.25 32,000 7.38 29,333 1.30 263,000 6.43 263,000 1.50 380,000 2.31 380,000 1.75 1,067 8.33 534 1.80 190,050 7.98 131,665 1.85 24,000 7.64 20,000 1.97 1,422 8.15 830 Total 2,508,503 2,340,842
Schedule of Other Share-based Compensation, Activity	The following table summarizes warrant activity: Weighted Average Number of Exercise Warrants Price Outstanding, June 30, 2015 305,000 $ 1.26 Granted - - Exercised - - Expired - - Outstanding, September 30, 2015 305,000 $ 1.26 Exercisable, June 30, 2015 305,000 $ 1.26 Exercisable, September 30, 2015 305,000 $ 1.26
Schedule of Stockholders' Equity Note, Warrants or Rights	Additional information regarding warrants outstanding and exercisable as of September 30, 2015 is as follows: Remaining Warrant Warrants Contractual Warrants Exercise Price Outstanding Life (in years) Exercisable $ 1.19 150,000 6.23 150,000 1.25 150,000 5.10 150,000 3.50 2,500 0.75 2,500 4.00 2,500 0.75 2,500 Total 305,000 305,000
Schedule of Nonvested Restricted Stock Units Activity	The following table summarizes restricted common stock activity: Weighted Average Number of Grant Date Shares Fair Value Non-vested, June 30, 2015 736,746 0.96 Granted 152,000 0.90 Vested (129,539) 0.92 Forfeited - - Non-vested, September 30, 2015 759,207 $ 0.95

Deconsolidation of Former Fre17

Deconsolidation of Former French Subsidiary (TAAG) (Tables)	3 Months Ended
	Sep. 30, 2015
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The gain from deconsolidation of the Company’s former French subsidiary consists of the following: Description Amount Current assets $ (1,239,713) Property and equipment, net (359,677) Noncurrent assets (499,070) Current liabilities 3,442,857 Long term liabilities 95,051 Accumulated other comprehensive income 108,847 Total $ 1,548,295
Schedule Of Disposal Groups Including Discontinued Operations Income Statement	Revenue and expenses from discontinued operations were as follows: Three Months Ended September 30, 2015 2014 Revenue $ - $ 1,164,314 Cost of revenue - 849,174 Gross profit - 315,140 Operating expenses: Selling, general and administrative - 660,500 Depreciation and amortization - 44,027 Total operating expenses - 704,527 Loss from discontinued operations before other income (expenses) - (389,387) Other income (expenses): Interest expense - (5,957) Loss from discontinued operations $ - $ (395,344) Basic loss per common share: Loss per share from discontinued operations $ - $ (0.02) Basic weighted average common shares outstanding - 17,406,012 Diluted loss per common share: Loss per share from discontinued operations $ - $ (0.02) Diluted weighted average common shares outstanding - 17,407,428

Organization, Nature of Busin18

Organization, Nature of Business and Basis of Presentation (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Deconsolidation, Gain (Loss), Amount	$ 0	$ 1,548,295
Taag [Member]
Deconsolidation, Gain (Loss), Amount		$ 1,548,295

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Details) - Customer A [Member]	3 Months Ended			12 Months Ended
	Sep. 30, 2015		Sep. 30, 2014	Jun. 30, 2015
Concentration Risk, Percentage	11.00%		11.00%
Customer Concentration Risk [Member]
Concentration Risk, Percentage		[1]		13.00%
[1]	Less than 10%

Summary of Significant Accoun20

Summary of Significant Accounting Policies (Details 1)	3 Months Ended
	Sep. 30, 2015		Sep. 30, 2014
Vendor A [Member]
Concentration Risk, Percentage	17.00%		14.00%
Vendor B [Member]
Concentration Risk, Percentage		[1]	13.00%
[1]	Less than 10%

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Details 2)	3 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Euro To us Dollar [Member]
Period end exchange rate	1.12	1.27	1.11	1.36
Average period exchange rate	1.11	1.33	1.20	1.36
Mexian peso To us Dollar [Member]
Period end exchange rate	0.06	0.07	0.06	0.08
Average period exchange rate	0.06	0.08	0.07	0.08

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Details 3) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Basic income (loss) per common share:
Loss from continuing operations	$ (178,820)	$ (6,936)
Income (loss) from discontinued operations	0	1,152,951
Net income (loss)	$ (178,820)	$ 1,146,015
Denominator:
Weighted average shares outstanding (basic)	17,564,070	17,406,012
Effect of dilutive unvested restricted common stock	0	0
Effect of dilutive stock options and warrants	0	1,416
Weighted average shares outstanding (diluted)	17,564,070	17,407,428
Income (loss) per share from continuing operations:
Basic	$ (0.01)	$ 0
Diluted	(0.01)	0
Income (loss) per share from discontinued operations:
Basic	0	0.07
Diluted	0	0.07
Net income (loss) per share:
Basic	(0.01)	0.07
Diluted	$ (0.01)	$ 0.07

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015
Cash, FDIC Insured Amount	$ 250,000
Foreign Currency Transaction Gain (Loss), before Tax	1,317	$ 10,847
Europe Financial Institutions [Member]
Deposits	$ 94,937		$ 112,880
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		904,998
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,508,503	1,948,351
Employee Stock Option [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	305,000

Line of Credit (Details Textual

Line of Credit (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Jul. 23, 2010	Sep. 30, 2015	Jun. 30, 2015
Line of Credit Facility, Interest Rate Description		the prime rate plus 5.25%
Line of Credit Facility, Remaining Borrowing Capacity		$ 1,600,000	$ 2,182,000
Line of Credit Facility, Interest Rate at Period End		5.75%
Silicon Valley Bank [Member]
Line of Credit Facility, Amount Outstanding	$ 4,000,000
Line Of Credit Facility Expiration Date 1		Oct. 31, 2017
Debt Instrument, Basis Spread on Variable Rate		2.25%
Line Of Credit Facility Minimum Amount Outstanding During Period		$ 800,000
Debt Instrument, Covenant Description		Financial covenants include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $600,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2015, plus 50% of the dollar value of equity issuances after October 1, 2015 and the principal amount of subordinated debt.
Percentage Of Eligible Accounts Receivable On Line Of Credit	80.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details)	3 Months Ended
	Sep. 30, 2015$ / sharesshares
Outstanding beginning balance Shares	2,466,836
Granted Shares	41,667
Options vesting Shares	0
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	2,508,503
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.22
Granted Weighted Average Exercise Price | $ / shares	0.86
Options vesting Weighted Average Exercise Price | $ / shares	0
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.22
Vested Options [Member]
Outstanding beginning balance Shares	2,256,254
Granted Shares	31,000
Options vesting Shares	53,588
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	2,340,842
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.21
Granted Weighted Average Exercise Price | $ / shares	0.85
Options vesting Weighted Average Exercise Price | $ / shares	1.24
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.21
Unvested Options [Member]
Outstanding beginning balance Shares	210,582
Granted Shares	10,667
Options vesting Shares	(53,588)
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	167,661
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.29
Granted Weighted Average Exercise Price | $ / shares	0.90
Options vesting Weighted Average Exercise Price | $ / shares	1.24
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.28

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2)	3 Months Ended
	Sep. 30, 2015$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	2,508,503
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	2,340,842
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	6,150
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	0
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.65
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 1 month 10 days
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	59,500
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	33,542
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.77
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 10 months 20 days
Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	16,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	16,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 10 months 24 days
Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	25,667
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	15,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.90
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 10 months 6 days
Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	370,890
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	347,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	3 years 5 months 1 day
Range Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	287,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	287,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.02
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	4 years 9 months 29 days
Range Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	158,445
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	150,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.05
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 7 months 24 days
Range Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	53,898
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	53,898
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.07
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 18 days
Range Nine [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	330,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	330,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.10
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 9 months 4 days
Range Ten [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	278,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	267,333
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 4 months 10 days
Range Eleven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	31,414
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	15,707
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.20
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 7 months 20 days
Range Twelve [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	32,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	29,333
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 4 months 17 days
Range Thirteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	263,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	263,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.30
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 5 months 5 days
Range Fourteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	380,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	380,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	2 years 3 months 22 days
Range Fifteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	1,067
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	534
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.75
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 3 months 29 days
Range Sixteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	190,050
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	131,665
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 11 months 23 days
Range Seventeen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	24,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	20,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.85
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 7 months 20 days
Range Eighteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	1,422
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	830
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.97
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 1 month 24 days

Stockholders' Equity (Details 3

Stockholders' Equity (Details 3) - Warrant [Member] - $ / shares	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Jun. 30, 2015
Non-vested, Beginning balance	305,000
Granted Number of Warrants	0
Exercised Number Warrants	0
Expired Number of Warrants	0
Non-vested, Ending balance	305,000
Exercisable Number of Warrants		305,000	305,000
Outstanding, Beginning balance Weighted Average Exercise Price	$ 1.26
Granted Weighted Average Exercise Price	0
Exercised Weighted Average Exercise Price	0
Expired Weighted Average Expired Price	0
Outstanding, Ending balance Weighted Average Exercise Price	1.26
Exercisable, Weighted Average Exercise Price	$ 1.26	$ 1.26	$ 1.26

Stockholders' Equity (Details 4

Stockholders' Equity (Details 4) - Warrant [Member] - $ / shares	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Warrant Exercise Price		$ 1.26
Warrants Outstanding	305,000	305,000
Warrants Exercisable	305,000	305,000
Range One [Member]
Warrant Exercise Price	$ 1.19
Warrants Outstanding	150,000
Warrants Outstanding Remaining Contractual Life (in years)	6 years 2 months 23 days
Warrants Exercisable	150,000
Range Two [Member]
Warrant Exercise Price	$ 1.25
Warrants Outstanding	150,000
Warrants Outstanding Remaining Contractual Life (in years)	5 years 1 month 6 days
Warrants Exercisable	150,000
Range Three [Member]
Warrant Exercise Price	$ 3.50
Warrants Outstanding	2,500
Warrants Outstanding Remaining Contractual Life (in years)	9 months
Warrants Exercisable	2,500
Range Four [Member]
Warrant Exercise Price	$ 4
Warrants Outstanding	2,500
Warrants Outstanding Remaining Contractual Life (in years)	9 months
Warrants Exercisable	2,500

Stockholders' Equity (Details 5

Stockholders' Equity (Details 5) - Restricted Common Stock	3 Months Ended
	Sep. 30, 2015$ / sharesshares
Non-vested, Beginning balance	736,746
Granted Number of Warrants	152,000
Vested, Number of shares	(129,539)
Forfeited, Number of shares	0
Non-vested, Ending balance	759,207
Non-Vested, Beginning balance weighted averge grant date fair value | $ / shares	$ 0.96
Granted Weighted Average Grant date Fair Value | $ / shares	0.90
Vested Weighted Average Grant date Fair Value | $ / shares	0.92
Forfeited Weighted Average Grant date Fair Value | $ / shares	0
Non-vested,Ending Balance Weighted Average Grant date Fair Value | $ / shares	$ 0.95

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Jun. 30, 2015	Sep. 30, 2015	Nov. 21, 2014	Nov. 07, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		1,314,842
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term		6 years 3 months 25 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		6 years 7 months 13 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value		$ 20,531
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value		13,456
Stock or Unit Option Plan Expense		56,574
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options		129,972
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 87,167
Stock Repurchased During Period, Shares		1,848
Stock Repurchased During Period, Value		$ 1,756
Restricted Stock [Member]
Stock or Unit Option Plan Expense	$ 405,504
Stock Issued During Period, Shares, Restricted Stock Award, Gross	889,321	152,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 971,897	$ 136,800
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value		87,167
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options		$ 616,026
Repurchase Program [Member]
Stock Repurchase Program, Authorized Amount				$ 250,000
Stock Repurchased During Period, Shares		53,300
Treasury Stock Acquired, Average Cost Per Share		$ 0.93
Stock Repurchased During Period, Value		$ 49,482
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 200,518
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			3,000,000
Minimum [Member] | Restricted Stock [Member]
Sale of Stock, Price Per Share		$ 0.90
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			5,000,000

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Net Income (Loss) Attributable to Parent	$ (178,820)	$ 1,146,015

Deconsolidation of Former Fre32

Deconsolidation of Former French Subsidiary (TAAG) (Details) - Former French Subsidiary [Member]	Sep. 30, 2014USD ($)
Current assets	$ (1,239,713)
Property and equipment, net	(359,677)
Noncurrent assets	(499,070)
Current liabilities	3,442,857
Long term liabilities	95,051
Accumulated other comprehensive income	108,847
Total	$ 1,548,295

Deconsolidation of Former Fre33

Deconsolidation of Former French Subsidiary (TAAG) (Details 2) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 0	$ 1,164,314
Cost of revenue	0	849,174
Gross profit	0	315,140
Operating expenses:
Selling, general and administrative	0	660,500
Depreciation and amortization	0	44,027
Total operating expenses	0	704,527
Loss from discontinued operations before other income (expenses)	0	(389,387)
Other income (expenses):
Interest expense	0	(5,957)
Loss from discontinued operations	$ 0	$ (395,344)
Basic loss per common share:
Loss per share from discontinued operations	$ 0	$ (0.02)
Basic weighted average common shares outstanding	17,564,070	17,406,012
Diluted loss per common share:
Loss per share from discontinued operations	$ 0	$ (0.02)
Diluted weighted average common shares outstanding	17,564,070	17,407,428